- Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis  

SEOUL, South Korea, Sep. 09, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced that Neurophet and NTU (Nanyang Technological University) Singapore have been recognized in the Asian Society Against Dementia (ASAD) conference for their joint research.

Neurophet has signed a joint research agreement partnering with the Lee Kong Chian School of Medicine, NTU in Singapore, to analyze data from the Dementia Research Centre.

Through this collaboration, Neurophet and NTU conducted joint research on automatic brain segmentation using "Neurophet AQUA".

Neurophet AQUA is AI-based brain MRI analysis software that segments and analyzes brain MRIs in 5 minutes and boasts a high analysis success rate. It analyzes and provides consistent results regardless of race, age, and gender.

The main aim of this study is to validate the use of the Neurophet AQUA segmentation and WMH quantification software in a Southeast Asian community-based cohort of cognitively normal, MCI (Mild cognitive impairment), and dementia subjects.

The study found that Neurophet AQUA offers several advantages such as shorter processing time and higher robustness. Also, its segmentation capabilities have been meticulously developed and validated for both East-Asian and Caucasian populations.

“This collaboration represents an exciting opportunity to enhance our impact especially in Southeast Asia,” said CEO Jake Junkil Been of Neurophet. “We will do our best to ensure that our products can be actively used across the market.”

The study “Automatic Brain Segmentation with AQUA: A Comparative Validation Study in the Southeast Asian BIOCIS Cohort” was presented with the Young Investigator Award at ASAD conference and will be published in an international Journal.